주식/증권
📈 긍정적
ResMed (RMD): Buy, Sell, or Hold Post Q2 Earnings?
요약
ResMed currently trades at $218.94 per share and has shown little upside over the past six months, posting a small loss of 2.7%. The stock also fell short of the S&P 500’s 15.9% gain during that period.